Dr. Bradley Hyman III, MD

• Neurology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• University Of Iowa Hospitals & Clinics

  Fellowship Hospital, 1989

• University Of Iowa Hospitals & Clinics

  Residency Hospital, 1987

• University Of Iowa Hospitals & Clinics

  Internship Hospital, 1985

• University Of Iowa Carver College Of Medicine

  Medical School, 1983

• APOE and Alzheimer's Disease: Advances in Genetics, Pathophysiology, and Therapeutic Approaches., 2021-03-20

• Amyloid deposition is associated with impaired default network function in older persons without dementia, 2009-07-30

• ?-Secretase Heterogeneity in the Aph1 Subunit: Relevance for Alzheimer's Disease, 2009-03-19

• Effect ofAPOEalleles on the glial transcriptome in normal aging and Alzheimer's disease, 2021-10-11

• Shared genetic risk between corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementia, 2017-03-07

• Reversible Cation-Selective Attachment and Self-Assembly of Human Tau on Supported Brain Lipid Membranes, 2018-04-17

• Performance Characteristics of Plasma Amyloid ß 40 and 42 Assays, 2009-05-28

• N-cadherin-based adhesion enhances Aß release and decreases Aß42/40ratio, 2008-11-25

• APOEe2 is associated with milder clinical and pathological Alzheimer's disease, 2015-04-20

• Associations of Lower Caffeine Intake and Plasma Urate Levels with Idiopathic Parkinson's Disease in the Harvard Biomarkers Study, 2020-07-10

• Differential effect of three-repeat and four-repeat tau on mitochondrial axonal transport, 2009-08-03

• The role of clusterin in amyloid-ß associated neurodegeneration, 2014-06-14

• INHIBITION OF THE NFAT PATHWAY ALLEVIATES AMYLOID BETA NEUROTOXICITY IN A MOUSE MODEL OF ALZHEIMER'S DISEASE, 2012-02-29

• Machine learning identifies candidates for drug repurposing in Alzheimer's disease, 2021-02-15

• Synaptic proteins associated with cognitive performance and neuropathology in older humans revealed by multiplexed fractionated proteomics, 2021-04-24

• Author Correction: [11C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer's disease, 2022-10-03

• Meta-analysis of mouse transcriptomic studies supports a context-dependent astrocyte reaction in acute CNS injury versus neurodegeneration, 2020-07-31

• In vivo rate-determining steps of tau seed accumulation in Alzheimer's disease, 2021-10-01

• Effects of Simvastatin on Cholesterol Metabolism and Alzheimer Disease Biomarkers, 2013-06-18

• Ubiquitinylation of a-Synuclein by Carboxyl Terminus Hsp70-Interacting Protein (CHIP) Is Regulated by Bcl-2-Associated Athanogene 5 (BAG5), 2011-02-16

• LRAD3, a Novel LDL Receptor Family Member that Modulates Amyloid Precursor Protein Trafficking, 2011-07-27

• Polygenic hazard score: an enrichment marker for Alzheimer's associated amyloid and tau deposition, 2017-11-24

• Polygenic hazard scores in preclinical Alzheimer's disease, 2017-12-16

• The Challenge of Connecting the Dots in the B.R.A.I.N, 2013-10-16

• Tau pathology does not affect experience-driven single-neuron and network-wideArc/Arg3.1responses, 2014-06-10

• Amyloid-ß associated volume loss occurs only in the presence of phospho-tau, 2011-10-14

• Dynamic presenilin 1 and synaptotagmin 1 interaction modulates exocytosis and amyloid ß production, 2017-02-13

• Distinct dendritic spine and nuclear phases of calcineurin activation after exposure to Amyloid ß revealed by a novel FRET assay, 2012-04-11

• Tangle-Bearing Neurons Survive Despite Disruption of Membrane Integrity in a Mouse Model of Tauopathy, 2009-07-16

• Genome-Encoded Cytoplasmic Double-Stranded RNAs, Found inC9ORF72ALS-FTD Brain, Propagate Neuronal Loss, 2021-07-07

• PTEN activation contributes to neuronal and synaptic engulfment by microglia in tauopathy, 2020-03-31

• Poor Performance on a Preoperative Cognitive Screening Test Predicts Postoperative Complications in Older Orthopedic Surgical Patients, 2017-08-03

• Polygenic Overlap Between C-Reactive Protein, Plasma Lipids and Alzheimer's Disease, 2015-04-10

• The SIST-M: Development, reliability and cross-sectional validation of a brief structured Clinical Dementia Rating interview, 2010-05-18

• Existing plaques and neuritic abnormalities in APP:PS1 mice are not affected by administration of the gamma-secretase inhibitor LY-411575, 2009-05-06

• A Luminex Assay Detects Amyloid ß Oligomers in Alzheimer's Disease Cerebrospinal Fluid, 2013-07-02

• Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid ß peptide, 2012-10-24

• Tau - amyloid interactions in the rTgTauEC model of early Alzheimer's disease suggest amyloid induced disruption of axonal projections and exacerbated axonal pathology, 2013-12-15

• EM Structure of the Ectodomain of Integrin CD11b/CD18 and Localization of Its Ligand-Binding Site Relative to the Plasma Membrane, 2013-02-28

• 3D Visualization of the Temporal and Spatial Spread of Tau Pathology Reveals Extensive Sites of Tau Accumulation Associated with Neuronal Loss and Recognition Memory Deficit in Aged Tau Transgenic Mice, 2016-07-28

• Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer's Disease, 2020-11-13

• Quantitative Methods for the Detection of Tau Seeding Activity in Human Biofluids, 2021-03-19

• Different tau species lead to heterogeneous tau pathology propagation and misfolding, 2018-11-29

• Regional cortical thinning and cerebrospinal biomarkers predict worsening daily functioning across the Alzheimer disease spectrum, 2014-01-01

• Common variants inMS4A4/MS4A6E, CD2uAP, CD33, andEPHA1are associated with late-onset Alzheimer's disease, 2011-04-03

• Caspase activation precedes and leads to tangles, 2010-03-31

• Regulation of tau internalization, degradation, and seeding by LRP1 reveals multiple pathways for tau catabolism, 2021-04-28

• Identification of neurotoxic cytokines by profiling Alzheimer's disease tissues and neuron culture viability screening, 2015-11-13

• Partial reduction of microglia does not affect tau pathology in aged mice, 2018-11-09

• Predictors of the Importance of Everyday Preferences for Older Adults with Cognitive Impairment, 2021-01-18

• Kinetics of tau aggregation reveals patient-specific tau characteristics among Alzheimer's cases, 2021-05-04

• Distinct rolesin vivofor the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of a-synuclein, 2011-10-12

• Causal inference in medical records and complementary systems pharmacology for metformin drug repurposing towards dementia, 2022-12-10

• Synaptic Tau Seeding Precedes Tau Pathology in Human Alzheimer's Disease Brain, 2018-04-24

• A reporter of local dendritic translocation shows plaque related loss of neural system function in APP transgenic mice, 2009-10-07

• Trafficking of AAV vectors across a model of the blood-brain barrier; a comparative study of transcytosis and transduction using primary human brain endothelial cells, 2016-12-15

• Technical Performance Evaluation of Olink Proximity Extension Assay for Blood-Based Biomarker Discovery in Longitudinal Studies of Alzheimer's Disease, 2022-06-06

• Structural Interactions between Inhibitor and Substrate Docking Sites Give Insight into Mechanisms of Human PS1 Complexes, 2014-01-07

• Tau propagation is dependent on the genetic background of mouse strains, 2022-02-23

• a-Synuclein Strains Target Distinct Brain Regions and Cell Types, 2019-12-02

• Gene Transfer of HumanApoeIsoforms Results in Differential Modulation of Amyloid Deposition and Neurotoxicity in Mouse Brain, 2013-11-20

• Conformational fingerprinting of tau variants and strains by Raman spectroscopy† † Electronic supplementary information (ESI) available. See DOI: 10.1039/d1ra00870f, 2021-02-26

• Frequent and symmetric deposition of misfolded tau oligomers within presynaptic and postsynaptic terminals in Alzheimer's disease, 2014-10-21

• Human tau increases amyloid ß plaque size but not amyloid ß-mediated synapse loss in a novel mouse model of Alzheimer's disease, 2016-11-12

• Rapid microglial response around amyloid pathology following systemic anti-Aß antibody administration in PDAPP mice, 2008-12-24

• Orchestrated experience-drivenArc/Arg3.1responses are disrupted in a mouse model of Alzheimer's disease, 2012-08-26

• Secretion and Uptake of a-Synuclein Via Extracellular Vesicles in Cultured Cells, 2018-10-04

• Identification of the novel activity-driven interaction between synaptotagmin 1 and presenilin 1 links calcium, synapse, and amyloid beta, 2016-03-31

• Endothelial Cells Are Heterogeneous in Different Brain Regions and Are Dramatically Altered in Alzheimer's Disease, 2023-06-14

• Size matters: the impact of nucleus size on results from spatial transcriptomics, 2023-04-21

• Longitudinal Changes in Neuropsychiatric Symptoms: Impact of Discrepancy in Everyday Preferences Between Persons with Cognitive Impairment and their Care Partners, 2021-10-24

• Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer's disease, 2015-03-24

• Genome-Wide Association Meta-analysis of Neuropathologic Features of Alzheimer's Disease and Related Dementias, 2014-09-04

• Continuous Monitoring of Tau-Induced Neurotoxicity in Patient-Derived iPSC-Neurons, 2021-05-12

• Improved design of prodromal Alzheimer's disease trials through cohort enrichment and surrogate endpoints, 2013-01-01

• A correlation map of genome-wide DNA methylation patterns between paired human brain and buccal samples, 2022-11-01

• Alzheimer's Disease Risk GeneCD33Inhibits Microglial Uptake of Amyloid Beta, 2013-04-25

• Systematic review of human post-mortem immunohistochemical studies and bioinformatics analyses unveil the complexity of astrocyte reaction in Alzheimer's disease, 2021-08-17

• Apolipoprotein E isoform does not influence trans-synaptic spread of tau pathology in a mouse model, 2023-08-17

• Tau reduction in aged mice does not impact Microangiopathy, 2020-08-18

• Somatic genomic changes in single Alzheimer's disease neurons, 2022-04-20

• Local Nucleation of Microtubule Bundles through Tubulin Concentration into a Condensed Tau Phase, 2017-09-05

• Neuronal uptake and propagation of a rare phosphorylated high-molecular-weight tau derived from Alzheimer's disease brain, 2015-10-13

• Alternatives to amyloid for Alzheimer's disease therapies-a symposium report, 2020-05-29

• Allosteric Modulation of PS1/?-Secretase Conformation Correlates with Amyloid ß42/40Ratio, 2009-11-18

• Neuronal calcineurin transcriptional targets parallel changes observed in Alzheimer disease brain, 2018-09-07

• The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease, 2011-04-21

• Tau protein disrupts nucleocytoplasmic transport in Alzheimer's disease, 2018-09-05

• Characterizing Clinical and Neuropathological Traits ofAPOEHaplotypes in African Americans and Europeans, 2020-12-18

• Comparison of Transduction Efficiency of Recombinant AAV Serotypes 1, 2, 5, and 8 in the Rat Nigrostriatal System, 2009-02-24

• Human LilrB2 Is a ß-Amyloid Receptor and Its Murine Homolog PirB Regulates Synaptic Plasticity in an Alzheimer's Model, 2013-09-20

• Tau impairs neural circuits, dominating amyloid-ß effects, in Alzheimer models in vivo, 2018-12-17

• Novel Progranulin Mutation Detected in 2 Patients With FTLD, 2013-06-18

• Amyloid Beta (Aß) Induces the Morphological Neurodegenerative Triad of Spine Loss, Dendritic Simplification, and Neuritic Dystrophies through Calcineurin (CaN) Activation, 2010-02-17

• Monitoring protein aggregation and toxicity in Alzheimer's disease mouse models using in vivo imaging, 2010-12-14

• Differences in Assessment of Everyday Preferences Between People With Cognitive Impairment and Their Care Partners: The Role of Neuropsychiatric Symptoms, 2020-02-06

• Association ofSNCAwith Parkinson: replication in the Harvard NeuroDiscovery Center Biomarker Study, 2011-09-23

• Soluble pathological tau in the entorhinal cortex leads to presynaptic deficits in an early Alzheimer's disease model, 2013-11-24

• Alzheimer's disease: synapses gone cold, 2011-08-26

• Preoperative Cognitive Stratification of Older Elective Surgical Patients: A Cross-Sectional Study, 2016-02-20

• Cyclic multiplex fluorescent immunohistochemistry and machine learning reveal distinct states of astrocytes and microglia in normal aging and Alzheimer's disease, 2022-02-02

• Massachusetts alzheimer's disease research center: Progress and challenges, 2015-08-19

• Preservation of Neuronal Number Despite Age-Related Cortical Brain Atrophy In Elderly Subjects Without Alzheimer Disease, 2009-08-14

• Characterization of TauC3 antibody and demonstration of its potential to block tau propagation, 2017-05-22

• Heterogeneity of Tau Deposition and Microvascular Involvement in MCI and AD, 2022-01-29

• Calcineurin inhibition with systemic FK506 treatment increases dendritic branching and dendritic spine density in healthy adult mouse brain, 2010-10-21

• Cerebrovascular Senescence Is Associated With Tau Pathology in Alzheimer's Disease, 2020-09-16

• Analysis of a-synuclein species enriched from cerebral cortex of humans with sporadic dementia with Lewy bodies, 2020-02-11

• The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers, 2013-06-18

• RNA Aptamer Probes as Optical Imaging Agents for the Detection of Amyloid Plaques, 2014-02-26

• Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score, 2017-03-21

• Genome-wide association study and functional validation implicates JADE1 in tauopathy, 2021-11-01

• Tau molecular diversity contributes to clinical heterogeneity in Alzheimer's disease, 2020-06-22

• Tau Causes Synapse Loss without Disrupting Calcium Homeostasis in the rTg4510 Model of Tauopathy, 2013-11-20

• Synaptic and metabolic gene expression alterations in neurons that are recipients of proteopathic tau seeds, 2020-10-19

• Synaptic alterations in the rTg4510 mouse model of tauopathy, 2013-04-15

• Dissecting the genetic relationship between cardiovascular risk factors and Alzheimer's disease, 2018-11-09

• Episodic Memory of Odors Stratifies Alzheimer Biomarkers in Normal Elderly, 2016-11-23

• Apolipoprotein E: Isoform Specific Differences in Tertiary Structure and Interaction with Amyloid-ß in Human Alzheimer Brain, 2011-01-31

• Entorhinal cortex: ante-mortem cortical thickness and post-mortem neurofibrillary tangle and amyloid pathology, 2017-03-09

• "Virus vector-mediated genetic modification of brain tumor stromal cells after intravenous delivery.”, 2018-05-16

• At the interface of sensory and motor dysfunctions and Alzheimer's Disease, 2014-07-09

• Soluble oligomeric amyloid-ß induces calcium dyshomeostasis that precedes synapse loss in the living mouse brain, 2017-03-21

• Preoperative Cognitive Assessment of the Elderly Surgical Patient: A Call For Action, 2011-05-09

• Systematic in silico analysis of clinically tested drugs for reducing amyloid-beta plaque accumulation in Alzheimer's disease, 2021-05-02

• Common genetic variants in theCLDN2andPRSS1-PRSS2loci alter risk for alcohol-related and sporadic pancreatitis, 2012-11-11

• Methylene blue does not reverse existing neurofibrillary tangle pathology in the rTg4510 mouse model of tauopathy, 2014-01-21

• Novel methods for integration and visualization of genomics and genetics data in Alzheimer's disease, 2019-03-29

• LRP1 is a master regulator of tau uptake and spread, 2020-04-01

• The SIST-M: Predictive validity of a brief structured Clinical Dementia Rating interview, 2011-09-23

• Regulation of dynamin oligomerization in cells: the role of dynamin-actin interactions and its GTPase activity, 2014-06-24

• Seed-competent HMW tau species accumulates in the cerebrospinal fluid of Alzheimer's disease mouse model and human patients, 2016-08-03

• Amyloid structure exhibits polymorphism on multiple length scales in human brain tissue, 2016-09-15

• Pathologic correlations of [F-18]-AV-1451 imaging in non-Alzheimer tauopathies, 2017-02-01

• Simultaneous multispectral reflectance imaging and laser speckle flowmetry of cerebral blood flow and oxygen metabolism in focal cerebral ischemia, 2009-10-27

• Soluble Tau Species, Not Neurofibrillary Aggregates, Disrupt Neural System Integration in a Tau Transgenic Model, 2011-05-24

• National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach, 2011-11-20

• Meta-analysis of Parkinson disease: Identification of a novel locus,RIT2, 2011-12-02

• Tissue libraries enable rapid determination of conditions that preserve antibody labeling in cleared mouse and human tissue, 2023-01-19

• ApoE4 reduction with ASOs decreases neurodegeneration in a tauopathy model, 2021-02-24

• Cerebrospinal Fluid Particles in Alzheimer Disease and Parkinson Disease, 2015-04-23

• Impairment of visual cortical plasticity by amyloid-beta species, 2021-03-22

• Alzheimer disease, 2021-05-13

• Genetic overlap between Alzheimer's disease and Parkinson's disease at theMAPTlocus, 2015-02-17

• A NovelGRNMutation (GRNc.708+6_+9delTGAG) in Frontotemporal Lobar Degeneration with TDP-43-positive Inclusions: Clinicopathologic Report of 6 Cases, 2014-06-21

• PART, a distinct tauopathy, different from classical sporadic Alzheimer disease, 2015-03-17

• Tau seeding and spreading in vivo is supported by both AD-derived fibrillar and oligomeric tau, 2023-06-21

• The role of microglia in processing and spreading of bioactive tau seeds in Alzheimer's disease, 2018-09-18

• Direct Visualization of CHIP-Mediated Degradation of Alpha-SynucleinIn Vivo: Implications for PD Therapeutics, 2014-03-24

• Exosome-associated AAV vector as a robust and convenient neuroscience tool, 2016-02-02

• Interaction of Reelin with APP promotes neurite outgrowth, 2009-06-10

• Heart fatty acid binding protein and Aß-associated Alzheimer's neurodegeneration, 2013-10-02

• Synaptic plasticity defect following visual deprivation in Alzheimer disease model transgenic mice, 2012-06-06

• Engulfment adapter PTB domain containing 1 (GULP1) is a nucleocytoplasmic shuttling protein and transactivationally active together with lowdensity lipoprotein receptor-related protein 1 (LRP1), 2013-03-01

• Soluble forms of tau are toxic in Alzheimer's disease, 2012-08-02

• Beyond the neuron-cellular interactions early in Alzheimer disease pathogenesis, 2019-05-14

• Alzheimer's Biomarkers and Future Decline in Cognitive Normal Older Adults, 2018-01-13

• Validating novel tau PET tracer [F-18]-AV-1451 (T807) on postmortem brain tissue, 2015-09-25

• Shorter Telomeres May Mark Early Risk of Dementia: Preliminary Analysis of 62 Participants from the Nurses' Health Study, 2008-02-13

• T cell mediated cerebral hemorrhages and microhemorrhages during passive Aß immunization in APPPS1 transgenic mice, 2011-03-09

• The G51DSNCAmutation generates a slowly progressive a-synuclein strain in early-onset Parkinson's disease, 2023-05-03

• The Feasibility of At-Home iPad Cognitive Testing For Use in Clinical Trials, 2015-11-15

• Neuronal Activity and Secreted Amyloid ß Lead to Altered Amyloid ß Precursor Protein and Presenilin 1 Interactions, 2012-10-12

• Primary age-related tauopathy (PART): a common pathology associated with human aging, 2014-10-28

• Specific detection of tau seeding activity in Alzheimer's disease using rationally designed biosensor cells, 2023-08-08

• Acetylated tau inhibits chaperone-mediated autophagy and promotes tau pathology propagation in mice, 2021-04-14

• [11C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer's disease, 2022-07-19

• Amyloid Related Imaging Abnormalities (ARIA) in Amyloid Modifying Therapeutic Trials: Recommendations from the Alzheimer's Association Research Roundtable Workgroup, 2013-06-03

• The Golgi-Localized ?-Ear-Containing ARF-Binding (GGA) Proteins Alter Amyloid-ß Precursor Protein (APP) Processing through Interaction of Their GAE Domain with the Beta-Site APP Cleaving Enzyme 1 (BACE1), 2015-06-08

• Mild to Moderate Alzheimer Dementia with Insufficient Neuropathological Changes, 2014-04-08

• Opposing Roles of apolipoprotein E in aging and neurodegeneration, 2019-02-13

• Behavioral deficits, early gliosis, dysmyelination and synaptic dysfunction in a mouse model of mucolipidosis IV, 2014-09-09

• Differential Relationships of Reactive Astrocytes and Microglia to Fibrillar Amyloid Deposits in Alzheimer Disease, 2013-05-09

• Stable Size Distribution of Amyloid Plaques Over the Course of Alzheimer Disease, 2012-06-18

• A multifactorial model of pathology for age of onset heterogeneity in familial Alzheimer's disease, 2020-12-14

• Direct detection of alpha synuclein oligomers in vivo, 2013-05-09

• The intersection of amyloid beta and tau at synapses in Alzheimer's disease, 2014-05-21

• Computational Interspecies Translation Between Alzheimer's Disease Mouse Models and Human Subjects Identifies Innate Immune Complement, TYROBP, and TAM Receptor Agonist Signatures, Distinct From Influences of Aging, 2021-09-30

• Longitudinal Differences in Everyday Preferences: Comparisons Between People with Cognitive Impairment and their Care Partners, 2021-09-08

• Signal peptide peptidase (SPP) dimer formation as assessed by fluorescence lifetime imaging microscopy (FLIM) in intact cells, 2006-11-14

• Propagation of tau pathology in a model of early Alzheimer's disease, 2012-02-23

• Dopamine-Induced Conformational Changes in Alpha-Synuclein, 2009-09-04

• A Nuclear Magnetic Resonance Spectroscopy Method in Characterization of Blood Metabolomics for Alzheimer's Disease, 2022-02-15

• Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment, 2023-03-02

• Mapping the Spatial Distribution of Fibrillar Polymorphs in Human Brain Tissue, 2022-06-01

• Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study, 2020-02-03

• APOE e4 does not modulate amyloid-ß associated neurodegeneration in preclinical Alzheimer's disease, 2012-09-13

• Systematic review and meta-analysis of human transcriptomics reveals neuroinflammation, deficient energy metabolism, and proteostasis failure across neurodegeneration, 2020-12-19

• National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease, 2011-11-14

• Studying synapses in human brain with array tomography and electron microscopy, 2013-06-20

• Calcineurin activation causes retinal ganglion cell degeneration, 2012-11-29

• Formation, release, and internalization of stable tau oligomers in cells, 2016-11-10

• Subjective cognitive concerns and neuropsychiatric predictors of progression to the early clinical stages of Alzheimer's disease, 2014-02-26

• Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aß, tau, immunity and lipid processing, 2019-02-28

• Alzheimer's disease-associated ubiquilin-1 regulates presenilin-1 accumulation and aggresome formation, 2011-01-07

• Spread of tau down neural circuits precedes synapse and neuronal loss in the rTgTauEC mouse model of early A lzheimer's disease PICKETT et al., 2017-03-06

• Interaction of the apolipoprotein E receptors low density lipoprotein receptorrelated protein and sorLA/LR11, 2008-11-08

• Mutant torsinA in the heterozygous DYT1 state compromises HSV propagation in infected neurons and fibroblasts, 2018-02-02

• Alpha-Synuclein S129 Phosphorylation Mutants Do Not Alter Nigrostriatal Toxicity in a Rat Model of Parkinson Disease, 2009-07-24

• Multisite assessment of NIA-AA guidelines for the neuropathologic evaluation of Alzheimer's disease, 2015-08-29

• Temporoparietal MRI Measures of Atrophy in Subjects with Mild Cognitive Impairment that Predict Subsequent Diagnosis of Alzheimer's Disease, 2008-12-26

• A highly sensitive novel immunoassay specifically detects low levels of soluble Aß oligomers in human cerebrospinal fluid, 2015-03-22